REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $900 | +10.2% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $817 | -3.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $843 | -50.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,711 | -26.3% | 100 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $2,322 | +31.5% | 100 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $1,766 | -35.1% | 100 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $2,720 | +36.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 4,763,380 | $129,088,000 | 18.25% |
| Atlas Venture Life Science Advisors, LLC | 3,209,627 | $86,981,000 | 7.99% |
| Redmile Group, LLC | 3,866,512 | $104,782,000 | 2.38% |
| FRAZIER MANAGEMENT LLC | 650,862 | $17,638,000 | 1.36% |
| Mesirow Financial Investment Management, Inc. | 15,326 | $415,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,075,464 | $29,145,000 | 1.03% |
| EMERALD ADVISERS, LLC | 989,958 | $26,828,000 | 0.99% |
| BVF INC/IL | 926,529 | $25,109,000 | 0.91% |
| Integral Health Asset Management, LLC | 100,000 | $2,710,000 | 0.75% |
| Artal Group S.A. | 900,000 | $24,390,000 | 0.66% |